The Association Between Antidepressant Exposure and Birth Defects

Few moments are more concerning to parents than learning that their infant has a birth defect. Compounding this news is the possibility that the medication used to manage the mother ’s mood disorder may have increased the risk for her infant developing a birth defect. As health care professionals, we have an enormous obligation to get the science right. In 2007, an editorial was published in response to 2 large case-control studies, “Teratogenicity of SSRIs: Serious Concern or Much Ado about Little?” What have we learned over the ensuing 13 years?
Source: JAMA Psychiatry - Category: Psychiatry Source Type: research